185 related articles for article (PubMed ID: 1304705)
21. Effect of praziquantel on the eggs of Schistosoma mansoni, with a note on the implications for managing central nervous system schistosomiasis.
Richards F; Sullivan J; Ruiz-Tiben E; Eberhard M; Bishop H
Ann Trop Med Parasitol; 1989 Oct; 83(5):465-72. PubMed ID: 2515814
[TBL] [Abstract][Full Text] [Related]
22. Parasitological and histopathological studies to the effect of aqueous extract of Moringa oleifera Lam. leaves combined with praziquantel therapy in modulating the liver and spleen damage induced by Schistosoma mansoni to male mice.
Saad El-Din MI; Gad El-Hak HN; Ghobashy MA; Elrayess RA
Environ Sci Pollut Res Int; 2023 Feb; 30(6):15548-15560. PubMed ID: 36169837
[TBL] [Abstract][Full Text] [Related]
23. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
[TBL] [Abstract][Full Text] [Related]
24. The potent effect of silymarin combination with Praziquantel or mirazid for Schistosoma mansoni treatment in infected male swiss albino mice.
El-Nagar DM; Al Olayan EM; Aloufi AS; Khatab AR
Trop Biomed; 2021 Mar; 38(1):22-27. PubMed ID: 33797519
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.
Tanaka M; Ohmae H; Utsunomiya H; Nara T; Irie Y; Yasuraoka K
Am J Trop Med Hyg; 1989 Aug; 41(2):198-203. PubMed ID: 2505624
[TBL] [Abstract][Full Text] [Related]
26. Niosomes for enhanced activity of praziquantel against Schistosoma mansoni: in vivo and in vitro evaluation.
Zoghroban HS; El-Kowrany SI; Aboul Asaad IA; El Maghraby GM; El-Nouby KA; Abd Elazeem MA
Parasitol Res; 2019 Jan; 118(1):219-234. PubMed ID: 30421348
[TBL] [Abstract][Full Text] [Related]
27. Effect of Curcuma longa or parziquantel on Schistosoma mansoni infected mice liver--histological and histochemical study.
El-Banhawey MA; Ashry MA; El-Ansary AK; Aly SA
Indian J Exp Biol; 2007 Oct; 45(10):877-89. PubMed ID: 17948736
[TBL] [Abstract][Full Text] [Related]
28. Propolis enhances the effectiveness of praziquantel in experimental schistosomiasis: biochemical and histopathological study.
Mahmoud TY; Rizk SM; Maghraby AS; Shaheen AA
Parasitol Res; 2014 Dec; 113(12):4513-23. PubMed ID: 25266217
[TBL] [Abstract][Full Text] [Related]
29. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.
Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E
J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111
[TBL] [Abstract][Full Text] [Related]
30. Itraconazole, a cytochrome P450 inhibitor, enhanced the efficacy of praziquantel against Schistosoma mansoni infection and alleviated liver injury in mice.
Sabra AA; Salem MB; William S; Hammam OA; El-Lakkany NM
Exp Parasitol; 2022 Aug; 239():108293. PubMed ID: 35667394
[TBL] [Abstract][Full Text] [Related]
31. A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection.
Radwan A; El-Lakkany NM; William S; El-Feky GS; Al-Shorbagy MY; Saleh S; Botros S
Parasit Vectors; 2019 Jun; 12(1):304. PubMed ID: 31208446
[TBL] [Abstract][Full Text] [Related]
32. Pathological and immunological evaluation of different regimens of praziquantel treatment in a mouse model of Schistosoma mansoni infection.
Membe Femoe U; Boukeng Jatsa H; Greigert V; Brunet J; Cannet C; Kenfack MC; Gipwe Feussom N; Kadji Fassi JB; Tienga Nkondo E; Abou-Bacar A; Pfaff AW; Dimo T; Kamtchouing P; Tchuem Tchuenté LA
PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010382. PubMed ID: 35446855
[TBL] [Abstract][Full Text] [Related]
33. Insulin growth factor inhibitor as a potential new anti-schistosoma drug: An in vivo experimental study.
Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; El-Karef AA; Abou-El-Wafa HS
Biomed Pharmacother; 2017 Nov; 95():1346-1358. PubMed ID: 28946182
[TBL] [Abstract][Full Text] [Related]
34. Anti-angiogenic and anti-proliferative activity of ziziphus leaf extract as a novel potential therapeutic agent for reducing hepatic injury in experimental hamster schistosomiasis.
Alghamdi T; Salem DA; El-Refaei MF
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011426. PubMed ID: 37339146
[TBL] [Abstract][Full Text] [Related]
35. Artemether as adjuvant therapy to praziquantel in murine Egyptian schistosomiasis mansoni.
Mahmoud MR; Botros SS
J Parasitol; 2005 Feb; 91(1):175-8. PubMed ID: 15856895
[TBL] [Abstract][Full Text] [Related]
36. Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.
Coeli R; Baba EH; Araujo N; Coelho PM; Oliveira G
PLoS Negl Trop Dis; 2013; 7(12):e2596. PubMed ID: 24367712
[TBL] [Abstract][Full Text] [Related]
37. Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment.
Miranda VHS; Gomes TR; Eller DE; Ferraz LCN; Chaves AT; Bicalho KA; Silva CEC; Birbrair A; Pascoal Xavier MA; de Goes AM; Corrêa-Oliveira R; Alves ÉAR; Bozzi A
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008635. PubMed ID: 32853206
[TBL] [Abstract][Full Text] [Related]
38. Anti-angiogenic and anti-lymphangiogenic role of praziquantel and artemether in experimental mansoniasis.
Abd El-Aal NF; Hamza RS; Magdy M
Acta Parasitol; 2017 Dec; 62(4):708-716. PubMed ID: 29035850
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.
Bajiro M; Dana D; Ayana M; Emana D; Mekonnen Z; Zawdie B; Garbi A; Kure A; Zeynudin A
Parasit Vectors; 2016 Oct; 9(1):560. PubMed ID: 27772528
[TBL] [Abstract][Full Text] [Related]
40. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
Fallon PG; Doenhoff MJ
Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
